Table 2 Risk factors predictive of disease extension in UC
Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
OR | 95.0% CI | p | OR | 95.0% CI | p | |
Gender | ||||||
female | 1.1 | 0.61–1.97 | 0.76 | |||
male | Reference | |||||
Age | ||||||
< 40 yrs. | 1.57 | 0.79–3.12 | 0.20 | |||
> 40 yrs | Reference | |||||
Smoker | ||||||
yes | 0.47 | 0.15–1.47 | 0.17 | |||
no | Reference | |||||
Extent | ||||||
Limited(E1/2) | 1.99 | 1.29–3.07 | < 0.01 | 1.74 | 1.18–2.57 | 0.01 |
extent | Reference | |||||
Disease severity | ||||||
severe vs | 1.1 | 0.58–2.10 | 0.77 | |||
mild | Reference | |||||
Corticosteroids use | ||||||
yes | 0.64 | 0.32–1.27 | 0.20 | |||
no | Reference | |||||
Immunosuppressive agents use | ||||||
yes | 0.47 | 0.24–0.91 | 0.02 | |||
no | Reference | |||||
Diagnostic delay | ||||||
< 6 months | 1.04 | 0.60–1.80 | 0.89 | |||
> 6 months | Reference | |||||